These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 30146257

  • 21. Suppressed mitochondrial respiration via NOX5-mediated redox imbalance contributes to the antitumor activity of anlotinib in oral squamous cell carcinoma.
    Huang Z, Su Q, Li W, Ren H, Huang H, Wang A.
    J Genet Genomics; 2021 Jul 20; 48(7):582-594. PubMed ID: 34373220
    [Abstract] [Full Text] [Related]

  • 22. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.
    Carcinogenesis; 2013 Jun 20; 34(6):1323-30. PubMed ID: 23404993
    [Abstract] [Full Text] [Related]

  • 23. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Han P, Li H, Jiang X, Zhai B, Tan G, Zhao D, Qiao H, Liu B, Jiang H, Sun X.
    Mol Oncol; 2017 Mar 20; 11(3):320-334. PubMed ID: 28164434
    [Abstract] [Full Text] [Related]

  • 24. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 20; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 25. NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells.
    Liu L, Chen J, Cao M, Wang J, Wang S.
    Cancer Chemother Pharmacol; 2019 Dec 20; 84(6):1303-1314. PubMed ID: 31555866
    [Abstract] [Full Text] [Related]

  • 26. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
    Lu M, Fei Z, Zhang G.
    Biomed Pharmacother; 2018 Jan 20; 97():1282-1288. PubMed ID: 29156516
    [Abstract] [Full Text] [Related]

  • 27. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
    Wang JG, Zheng XX, Zeng GY, Zhou YJ, Yuan H.
    Oncol Rep; 2014 Jan 20; 31(1):488-96. PubMed ID: 24247909
    [Abstract] [Full Text] [Related]

  • 28. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway.
    Zhang X, Shao J, Li X, Cui L, Tan Z.
    Oncol Rep; 2019 Feb 20; 41(2):1067-1074. PubMed ID: 30483804
    [Abstract] [Full Text] [Related]

  • 29. Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma.
    Tang H, You T, Ge H, Gao J, Wang Y, Bai C, Sun Z, Han Q, Zhao RC.
    Int Immunopharmacol; 2024 May 30; 133():112053. PubMed ID: 38615380
    [Abstract] [Full Text] [Related]

  • 30. 7-Deoxynarciclasine shows promising antitumor efficacy by targeting Akt against hepatocellular carcinoma.
    Yin S, Qiu Y, Jin C, Wang R, Wu S, Liu H, Koo S, Han L, Zhang Y, Gao X, Pang X, Wang T, Yu H.
    Int J Cancer; 2019 Dec 15; 145(12):3334-3346. PubMed ID: 31081930
    [Abstract] [Full Text] [Related]

  • 31. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism].
    Lin F, Yan W, Wen T, Wu GY.
    Zhonghua Zhong Liu Za Zhi; 2013 Oct 15; 35(10):742-6. PubMed ID: 24378094
    [Abstract] [Full Text] [Related]

  • 32. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H, Chen F, Zhang L, Zhou Q, Gui S, Wang Y.
    Oncol Rep; 2016 Jul 15; 36(1):333-41. PubMed ID: 27177208
    [Abstract] [Full Text] [Related]

  • 33. Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT.
    Zhou HH, Chen L, Liang HF, Li GZ, Zhang BX, Chen XP.
    Int J Mol Sci; 2016 Apr 22; 17(4):. PubMed ID: 27110775
    [Abstract] [Full Text] [Related]

  • 34. Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.
    Lu Y, Lin J, Duan M, Rui Y, Zheng H, Zhu L, Zhu X, Wei J.
    Anal Cell Pathol (Amst); 2021 Apr 22; 2021():5228713. PubMed ID: 34926131
    [Abstract] [Full Text] [Related]

  • 35. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R.
    Oncotarget; 2016 Mar 01; 7(9):9718-31. PubMed ID: 26756219
    [Abstract] [Full Text] [Related]

  • 36. Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell line.
    Yan CM, Chai EQ, Cai HY, Miao GY, Ma W.
    Mol Med Rep; 2015 Jun 01; 11(6):4617-24. PubMed ID: 25634350
    [Abstract] [Full Text] [Related]

  • 37. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
    Fan C, Zheng W, Fu X, Li X, Wong YS, Chen T.
    Oncotarget; 2014 May 15; 5(9):2853-63. PubMed ID: 24797310
    [Abstract] [Full Text] [Related]

  • 38. Bioactive components and mechanisms of poplar propolis in inhibiting proliferation of human hepatocellular carcinoma HepG2 cells.
    Liu H, Li J, Yuan W, Hao S, Wang M, Wang F, Xuan H.
    Biomed Pharmacother; 2021 Dec 15; 144():112364. PubMed ID: 34700230
    [Abstract] [Full Text] [Related]

  • 39. Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma In Vitro and In Vivo.
    Tsai JJ, Pan PJ, Hsu FT, Chung JG, Chiang IT.
    Am J Chin Med; 2020 Dec 15; 48(1):223-244. PubMed ID: 32054305
    [Abstract] [Full Text] [Related]

  • 40. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H, Ge C, Sun H, Li H, Li J, Tian H.
    Cancer Sci; 2018 Apr 15; 109(4):1088-1100. PubMed ID: 29377347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.